GC Genome Corporation (KOSDAQ:340450)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,910.00
-90.00 (-1.00%)
Jul 21, 2025, 3:30 PM KST

GC Genome Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Debt / Equity Ratio
0.140.140.470.400.740.66
Upgrade
Debt / EBITDA Ratio
1.702.353.18--12.64
Upgrade
Debt / FCF Ratio
1.7494.54----
Upgrade
Asset Turnover
-0.620.600.530.440.49
Upgrade
Inventory Turnover
-11.9611.5614.85--
Upgrade
Quick Ratio
2.833.741.002.136.2612.49
Upgrade
Current Ratio
3.194.271.122.326.4212.64
Upgrade
Return on Equity (ROE)
--4.32%-2.13%-16.52%1.56%-0.02%
Upgrade
Return on Assets (ROA)
--1.85%0.22%-4.43%-3.13%-0.01%
Upgrade
Return on Capital (ROIC)
--2.07%0.27%-5.76%-4.11%-0.01%
Upgrade
Return on Capital Employed (ROCE)
--0.50%---
Upgrade
Buyback Yield / Dilution
-16.78%0.66%-13.53%-0.97%10.25%-90.88%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.